Effect of Rebamipide(Mucosta) eye drops for corneal epithelial defect after cornea transplant

Effect of Rebamipide(Mucosta) eye drops for corneal epithelial defect after cornea transplant - Effect of Rebamipide(Mucosta) eye drops for corneal epithelial defect after cornea transplant

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011528

Enrollment

Registered

2013-08-20

Start date

2013-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corneal epithelial defect

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of corneal epithelial defect more than 30% in 5 days after corneal transplant

Exclusion criteria

Exclusion criteria: limbal dysfunction, changes of treatment after entry

Design outcomes

Primary

Measure	Time frame
Improvement of the corneal epithelial defect	—

Countries

Japan

Outcome results